nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—CYP2C9—brain cancer	0.647	1	CbGaD
Trimethoprim—CYP3A4—Temozolomide—brain cancer	0.0527	0.344	CbGbCtD
Trimethoprim—CYP3A4—Lomustine—brain cancer	0.0448	0.293	CbGbCtD
Trimethoprim—CYP2C8—Etoposide—brain cancer	0.0267	0.174	CbGbCtD
Trimethoprim—ABCB1—Etoposide—brain cancer	0.0181	0.118	CbGbCtD
Trimethoprim—CYP3A4—Etoposide—brain cancer	0.0108	0.0707	CbGbCtD
Trimethoprim—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00255	0.0402	CbGpPWpGaD
Trimethoprim—TYMS—Podofilox—Etoposide—brain cancer	0.0023	1	CbGdCrCtD
Trimethoprim—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00229	0.0362	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—HIC1—brain cancer	0.0022	0.0347	CbGpPWpGaD
Trimethoprim—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00208	0.0329	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—HIC1—brain cancer	0.00192	0.0303	CbGpPWpGaD
Trimethoprim—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00177	0.028	CbGpPWpGaD
Trimethoprim—DHFR—G1/S-Specific Transcription—CCNE1—brain cancer	0.00149	0.0235	CbGpPWpGaD
Trimethoprim—DHFR—One Carbon Metabolism—DNMT1—brain cancer	0.0014	0.0221	CbGpPWpGaD
Trimethoprim—DHFR—G1/S-Specific Transcription—PCNA—brain cancer	0.00132	0.0209	CbGpPWpGaD
Trimethoprim—TYMS—G1/S-Specific Transcription—CCNE1—brain cancer	0.0013	0.0205	CbGpPWpGaD
Trimethoprim—Pancytopenia—Lomustine—brain cancer	0.00128	0.0101	CcSEcCtD
Trimethoprim—DHFR—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.00126	0.0199	CbGpPWpGaD
Trimethoprim—TYMS—One Carbon Metabolism—DNMT1—brain cancer	0.00122	0.0193	CbGpPWpGaD
Trimethoprim—Renal failure—Lomustine—brain cancer	0.00118	0.00931	CcSEcCtD
Trimethoprim—Stomatitis—Lomustine—brain cancer	0.00117	0.00923	CcSEcCtD
Trimethoprim—TYMS—G1/S-Specific Transcription—PCNA—brain cancer	0.00115	0.0182	CbGpPWpGaD
Trimethoprim—Photosensitivity—Procarbazine—brain cancer	0.00113	0.00888	CcSEcCtD
Trimethoprim—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00112	0.00879	CcSEcCtD
Trimethoprim—Vascular purpura—Procarbazine—brain cancer	0.00111	0.00872	CcSEcCtD
Trimethoprim—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.0011	0.0174	CbGpPWpGaD
Trimethoprim—TYMS—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.0011	0.0173	CbGpPWpGaD
Trimethoprim—Haemolytic anaemia—Procarbazine—brain cancer	0.0011	0.00864	CcSEcCtD
Trimethoprim—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00106	0.0167	CbGpPWpGaD
Trimethoprim—Purpura—Procarbazine—brain cancer	0.00103	0.00809	CcSEcCtD
Trimethoprim—Lethargy—Procarbazine—brain cancer	0.00101	0.00796	CcSEcCtD
Trimethoprim—Ataxia—Procarbazine—brain cancer	0.000931	0.00734	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.000891	0.00703	CcSEcCtD
Trimethoprim—DHFR—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.000876	0.0138	CbGpPWpGaD
Trimethoprim—Hepatic enzyme increased—Temozolomide—brain cancer	0.000872	0.00687	CcSEcCtD
Trimethoprim—Eosinophilia—Procarbazine—brain cancer	0.000847	0.00668	CcSEcCtD
Trimethoprim—Leukopenia—Lomustine—brain cancer	0.00084	0.00662	CcSEcCtD
Trimethoprim—Pancreatitis—Procarbazine—brain cancer	0.000839	0.00661	CcSEcCtD
Trimethoprim—Pancytopenia—Procarbazine—brain cancer	0.000812	0.0064	CcSEcCtD
Trimethoprim—Dermatitis bullous—Hydroxyurea—brain cancer	0.000801	0.00632	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Procarbazine—brain cancer	0.000781	0.00615	CcSEcCtD
Trimethoprim—DHFR—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.000776	0.0123	CbGpPWpGaD
Trimethoprim—Aplastic anaemia—Temozolomide—brain cancer	0.000774	0.0061	CcSEcCtD
Trimethoprim—Pneumonia—Procarbazine—brain cancer	0.000767	0.00605	CcSEcCtD
Trimethoprim—TYMS—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.000765	0.0121	CbGpPWpGaD
Trimethoprim—Thrombocytopenia—Lomustine—brain cancer	0.00075	0.00591	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Procarbazine—brain cancer	0.000748	0.00589	CcSEcCtD
Trimethoprim—Stomatitis—Procarbazine—brain cancer	0.000743	0.00586	CcSEcCtD
Trimethoprim—Anorexia—Lomustine—brain cancer	0.00073	0.00576	CcSEcCtD
Trimethoprim—Haematuria—Procarbazine—brain cancer	0.000727	0.00573	CcSEcCtD
Trimethoprim—Epistaxis—Procarbazine—brain cancer	0.000719	0.00567	CcSEcCtD
Trimethoprim—Body temperature increased—Carboplatin—brain cancer	0.000692	0.00546	CcSEcCtD
Trimethoprim—Hallucination—Procarbazine—brain cancer	0.000681	0.00537	CcSEcCtD
Trimethoprim—TYMS—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.000677	0.0107	CbGpPWpGaD
Trimethoprim—Vascular purpura—Temozolomide—brain cancer	0.000669	0.00527	CcSEcCtD
Trimethoprim—Decreased appetite—Lomustine—brain cancer	0.000666	0.00525	CcSEcCtD
Trimethoprim—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000658	0.0104	CbGpPWpGaD
Trimethoprim—Pancreatitis—Hydroxyurea—brain cancer	0.000649	0.00512	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Temozolomide—brain cancer	0.000634	0.005	CcSEcCtD
Trimethoprim—Pancytopenia—Hydroxyurea—brain cancer	0.000629	0.00496	CcSEcCtD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000626	0.0099	CbGpPWpGaD
Trimethoprim—Hyponatraemia—Carmustine—brain cancer	0.000622	0.0049	CcSEcCtD
Trimethoprim—Purpura—Temozolomide—brain cancer	0.000621	0.00489	CcSEcCtD
Trimethoprim—Neutropenia—Hydroxyurea—brain cancer	0.000619	0.00488	CcSEcCtD
Trimethoprim—Body temperature increased—Lomustine—brain cancer	0.000606	0.00477	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000601	0.0095	CbGpPWpGaD
Trimethoprim—Infestation—Hydroxyurea—brain cancer	0.00059	0.00465	CcSEcCtD
Trimethoprim—Infestation NOS—Hydroxyurea—brain cancer	0.00059	0.00465	CcSEcCtD
Trimethoprim—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00059	0.00932	CbGpPWpGaD
Trimethoprim—Ataxia—Carmustine—brain cancer	0.000582	0.00459	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000579	0.00456	CcSEcCtD
Trimethoprim—Stomatitis—Hydroxyurea—brain cancer	0.000575	0.00454	CcSEcCtD
Trimethoprim—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000567	0.00897	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000565	0.00893	CbGpPWpGaD
Trimethoprim—Ataxia—Temozolomide—brain cancer	0.000563	0.00444	CcSEcCtD
Trimethoprim—Tremor—Procarbazine—brain cancer	0.000558	0.0044	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000558	0.0044	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—NTRK3—brain cancer	0.00055	0.00869	CbGpPWpGaD
Trimethoprim—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000539	0.00425	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000536	0.00847	CbGpPWpGaD
Trimethoprim—Syncope—Procarbazine—brain cancer	0.000535	0.00421	CcSEcCtD
Trimethoprim—Leukopenia—Procarbazine—brain cancer	0.000534	0.00421	CcSEcCtD
Trimethoprim—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000528	0.00835	CbGpPWpGaD
Trimethoprim—Hallucination—Hydroxyurea—brain cancer	0.000527	0.00416	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000525	0.00829	CbGpPWpGaD
Trimethoprim—Loss of consciousness—Procarbazine—brain cancer	0.000524	0.00413	CcSEcCtD
Trimethoprim—Cough—Procarbazine—brain cancer	0.00052	0.0041	CcSEcCtD
Trimethoprim—Convulsion—Procarbazine—brain cancer	0.000516	0.00407	CcSEcCtD
Trimethoprim—Pancytopenia—Carmustine—brain cancer	0.000508	0.00401	CcSEcCtD
Trimethoprim—Arthralgia—Procarbazine—brain cancer	0.000507	0.004	CcSEcCtD
Trimethoprim—Myalgia—Procarbazine—brain cancer	0.000507	0.004	CcSEcCtD
Trimethoprim—Anxiety—Procarbazine—brain cancer	0.000506	0.00399	CcSEcCtD
Trimethoprim—DHFR—G1/S Transition—SKP2—brain cancer	0.000502	0.00793	CbGpPWpGaD
Trimethoprim—Neutropenia—Carmustine—brain cancer	0.0005	0.00394	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000493	0.00779	CbGpPWpGaD
Trimethoprim—Pancytopenia—Temozolomide—brain cancer	0.000491	0.00387	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—SOD2—brain cancer	0.000491	0.00775	CbGpPWpGaD
Trimethoprim—Confusional state—Procarbazine—brain cancer	0.000491	0.00387	CcSEcCtD
Trimethoprim—Vomiting—Lomustine—brain cancer	0.000487	0.00384	CcSEcCtD
Trimethoprim—Neutropenia—Temozolomide—brain cancer	0.000484	0.00381	CcSEcCtD
Trimethoprim—Pneumonia—Carmustine—brain cancer	0.00048	0.00378	CcSEcCtD
Trimethoprim—Shock—Procarbazine—brain cancer	0.000479	0.00377	CcSEcCtD
Trimethoprim—Thrombocytopenia—Procarbazine—brain cancer	0.000476	0.00375	CcSEcCtD
Trimethoprim—Depression—Carmustine—brain cancer	0.000476	0.00375	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Temozolomide—brain cancer	0.000472	0.00372	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—SIRT1—brain cancer	0.00047	0.00743	CbGpPWpGaD
Trimethoprim—Renal failure—Carmustine—brain cancer	0.000469	0.0037	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Carmustine—brain cancer	0.000468	0.00369	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000468	0.00739	CbGpPWpGaD
Trimethoprim—Stomatitis—Carmustine—brain cancer	0.000465	0.00367	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—CCNE1—brain cancer	0.000464	0.00734	CbGpPWpGaD
Trimethoprim—Pneumonia—Temozolomide—brain cancer	0.000464	0.00366	CcSEcCtD
Trimethoprim—Anorexia—Procarbazine—brain cancer	0.000464	0.00365	CcSEcCtD
Trimethoprim—Erythema—Hydroxyurea—brain cancer	0.000461	0.00364	CcSEcCtD
Trimethoprim—Infestation—Temozolomide—brain cancer	0.000461	0.00363	CcSEcCtD
Trimethoprim—Infestation NOS—Temozolomide—brain cancer	0.000461	0.00363	CcSEcCtD
Trimethoprim—Depression—Temozolomide—brain cancer	0.00046	0.00362	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000457	0.0036	CcSEcCtD
Trimethoprim—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000456	0.00721	CbGpPWpGaD
Trimethoprim—Nausea—Lomustine—brain cancer	0.000455	0.00359	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Temozolomide—brain cancer	0.000452	0.00356	CcSEcCtD
Trimethoprim—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00045	0.00712	CbGpPWpGaD
Trimethoprim—Stomatitis—Temozolomide—brain cancer	0.00045	0.00354	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000443	0.00349	CcSEcCtD
Trimethoprim—Insomnia—Procarbazine—brain cancer	0.00044	0.00347	CcSEcCtD
Trimethoprim—TYMS—telencephalon—brain cancer	0.000438	0.0592	CbGeAlD
Trimethoprim—TYMS—G1/S Transition—SKP2—brain cancer	0.000438	0.00692	CbGpPWpGaD
Trimethoprim—Hepatobiliary disease—Temozolomide—brain cancer	0.000436	0.00344	CcSEcCtD
Trimethoprim—DHFR—telencephalon—brain cancer	0.000434	0.0586	CbGeAlD
Trimethoprim—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000431	0.0034	CcSEcCtD
Trimethoprim—Hallucination—Carmustine—brain cancer	0.000426	0.00336	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000423	0.00668	CbGpPWpGaD
Trimethoprim—Decreased appetite—Procarbazine—brain cancer	0.000423	0.00333	CcSEcCtD
Trimethoprim—Connective tissue disorder—Carmustine—brain cancer	0.000421	0.00332	CcSEcCtD
Trimethoprim—Constipation—Procarbazine—brain cancer	0.000416	0.00328	CcSEcCtD
Trimethoprim—Leukopenia—Hydroxyurea—brain cancer	0.000413	0.00325	CcSEcCtD
Trimethoprim—Hallucination—Temozolomide—brain cancer	0.000412	0.00325	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—SIRT1—brain cancer	0.00041	0.00648	CbGpPWpGaD
Trimethoprim—Urinary tract disorder—Temozolomide—brain cancer	0.000409	0.00322	CcSEcCtD
Trimethoprim—Connective tissue disorder—Temozolomide—brain cancer	0.000407	0.00321	CcSEcCtD
Trimethoprim—Urethral disorder—Temozolomide—brain cancer	0.000406	0.0032	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—CCNE1—brain cancer	0.000405	0.0064	CbGpPWpGaD
Trimethoprim—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000405	0.0064	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000404	0.00638	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Procarbazine—brain cancer	0.000401	0.00316	CcSEcCtD
Trimethoprim—Eye disorder—Carmustine—brain cancer	0.0004	0.00316	CcSEcCtD
Trimethoprim—Convulsion—Hydroxyurea—brain cancer	0.0004	0.00315	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Procarbazine—brain cancer	0.000398	0.00314	CcSEcCtD
Trimethoprim—Pancytopenia—Etoposide—brain cancer	0.000393	0.0031	CcSEcCtD
Trimethoprim—Erythema multiforme—Temozolomide—brain cancer	0.000391	0.00309	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00039	0.00307	CcSEcCtD
Trimethoprim—Neutropenia—Etoposide—brain cancer	0.000387	0.00305	CcSEcCtD
Trimethoprim—Eye disorder—Temozolomide—brain cancer	0.000387	0.00305	CcSEcCtD
Trimethoprim—Urticaria—Procarbazine—brain cancer	0.000386	0.00305	CcSEcCtD
Trimethoprim—Tinnitus—Temozolomide—brain cancer	0.000386	0.00304	CcSEcCtD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000386	0.0061	CbGpPWpGaD
Trimethoprim—Abdominal pain—Procarbazine—brain cancer	0.000385	0.00303	CcSEcCtD
Trimethoprim—Body temperature increased—Procarbazine—brain cancer	0.000385	0.00303	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000377	0.00596	CbGpPWpGaD
Trimethoprim—Mental disorder—Carmustine—brain cancer	0.000375	0.00296	CcSEcCtD
Trimethoprim—Immune system disorder—Temozolomide—brain cancer	0.000374	0.00295	CcSEcCtD
Trimethoprim—Mediastinal disorder—Temozolomide—brain cancer	0.000373	0.00294	CcSEcCtD
Trimethoprim—Erythema—Carmustine—brain cancer	0.000373	0.00294	CcSEcCtD
Trimethoprim—Malnutrition—Carmustine—brain cancer	0.000373	0.00294	CcSEcCtD
Trimethoprim—Pneumonia—Etoposide—brain cancer	0.000371	0.00293	CcSEcCtD
Trimethoprim—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00037	0.00585	CbGpPWpGaD
Trimethoprim—Nervous system disorder—Hydroxyurea—brain cancer	0.000369	0.00291	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000369	0.00583	CbGpPWpGaD
Trimethoprim—Infestation NOS—Etoposide—brain cancer	0.000369	0.00291	CcSEcCtD
Trimethoprim—Infestation—Etoposide—brain cancer	0.000369	0.00291	CcSEcCtD
Trimethoprim—Thrombocytopenia—Hydroxyurea—brain cancer	0.000369	0.00291	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000366	0.00288	CcSEcCtD
Trimethoprim—TYMS—gonad—brain cancer	0.000366	0.0494	CbGeAlD
Trimethoprim—Skin disorder—Hydroxyurea—brain cancer	0.000366	0.00288	CcSEcCtD
Trimethoprim—Renal failure—Etoposide—brain cancer	0.000363	0.00286	CcSEcCtD
Trimethoprim—Mental disorder—Temozolomide—brain cancer	0.000363	0.00286	CcSEcCtD
Trimethoprim—DHFR—gonad—brain cancer	0.000362	0.0489	CbGeAlD
Trimethoprim—Neuropathy peripheral—Etoposide—brain cancer	0.000362	0.00285	CcSEcCtD
Trimethoprim—Malnutrition—Temozolomide—brain cancer	0.00036	0.00284	CcSEcCtD
Trimethoprim—Erythema—Temozolomide—brain cancer	0.00036	0.00284	CcSEcCtD
Trimethoprim—Stomatitis—Etoposide—brain cancer	0.00036	0.00284	CcSEcCtD
Trimethoprim—Anorexia—Hydroxyurea—brain cancer	0.000359	0.00283	CcSEcCtD
Trimethoprim—Hypersensitivity—Procarbazine—brain cancer	0.000358	0.00282	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000358	0.00565	CbGpPWpGaD
Trimethoprim—DHFR—pituitary gland—brain cancer	0.000353	0.0477	CbGeAlD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000352	0.00556	CbGpPWpGaD
Trimethoprim—Tremor—Carmustine—brain cancer	0.000349	0.00275	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Etoposide—brain cancer	0.000349	0.00275	CcSEcCtD
Trimethoprim—Agranulocytosis—Etoposide—brain cancer	0.000344	0.00271	CcSEcCtD
Trimethoprim—Pruritus—Procarbazine—brain cancer	0.000344	0.00271	CcSEcCtD
Trimethoprim—Agitation—Carmustine—brain cancer	0.000343	0.0027	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000342	0.0054	CbGpPWpGaD
Trimethoprim—DHFR—medulla oblongata—brain cancer	0.000341	0.0461	CbGeAlD
Trimethoprim—Tremor—Temozolomide—brain cancer	0.000338	0.00266	CcSEcCtD
Trimethoprim—DHFR—G1/S Transition—CCNE1—brain cancer	0.000337	0.00532	CbGpPWpGaD
Trimethoprim—Dyspnoea—Hydroxyurea—brain cancer	0.000336	0.00265	CcSEcCtD
Trimethoprim—Leukopenia—Carmustine—brain cancer	0.000334	0.00263	CcSEcCtD
Trimethoprim—Diarrhoea—Procarbazine—brain cancer	0.000333	0.00262	CcSEcCtD
Trimethoprim—Dyspepsia—Hydroxyurea—brain cancer	0.000331	0.00261	CcSEcCtD
Trimethoprim—Agitation—Temozolomide—brain cancer	0.000331	0.00261	CcSEcCtD
Trimethoprim—Angioedema—Temozolomide—brain cancer	0.000329	0.0026	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000329	0.0052	CbGpPWpGaD
Trimethoprim—Decreased appetite—Hydroxyurea—brain cancer	0.000327	0.00258	CcSEcCtD
Trimethoprim—Urinary tract disorder—Etoposide—brain cancer	0.000327	0.00258	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000325	0.00256	CcSEcCtD
Trimethoprim—Urethral disorder—Etoposide—brain cancer	0.000325	0.00256	CcSEcCtD
Trimethoprim—Vertigo—Temozolomide—brain cancer	0.000324	0.00255	CcSEcCtD
Trimethoprim—Convulsion—Carmustine—brain cancer	0.000323	0.00255	CcSEcCtD
Trimethoprim—Leukopenia—Temozolomide—brain cancer	0.000323	0.00254	CcSEcCtD
Trimethoprim—Constipation—Hydroxyurea—brain cancer	0.000322	0.00254	CcSEcCtD
Trimethoprim—Dizziness—Procarbazine—brain cancer	0.000322	0.00254	CcSEcCtD
Trimethoprim—Myalgia—Carmustine—brain cancer	0.000317	0.0025	CcSEcCtD
Trimethoprim—Anxiety—Carmustine—brain cancer	0.000316	0.00249	CcSEcCtD
Trimethoprim—TYMS—midbrain—brain cancer	0.000315	0.0425	CbGeAlD
Trimethoprim—Cough—Temozolomide—brain cancer	0.000314	0.00248	CcSEcCtD
Trimethoprim—Erythema multiforme—Etoposide—brain cancer	0.000313	0.00247	CcSEcCtD
Trimethoprim—Convulsion—Temozolomide—brain cancer	0.000312	0.00246	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000312	0.00493	CbGpPWpGaD
Trimethoprim—DHFR—midbrain—brain cancer	0.000312	0.0421	CbGeAlD
Trimethoprim—Feeling abnormal—Hydroxyurea—brain cancer	0.00031	0.00245	CcSEcCtD
Trimethoprim—Eye disorder—Etoposide—brain cancer	0.00031	0.00244	CcSEcCtD
Trimethoprim—Vomiting—Procarbazine—brain cancer	0.000309	0.00244	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000309	0.00488	CbGpPWpGaD
Trimethoprim—Confusional state—Carmustine—brain cancer	0.000307	0.00242	CcSEcCtD
Trimethoprim—Myalgia—Temozolomide—brain cancer	0.000307	0.00242	CcSEcCtD
Trimethoprim—Arthralgia—Temozolomide—brain cancer	0.000307	0.00242	CcSEcCtD
Trimethoprim—Rash—Procarbazine—brain cancer	0.000307	0.00242	CcSEcCtD
Trimethoprim—Dermatitis—Procarbazine—brain cancer	0.000306	0.00242	CcSEcCtD
Trimethoprim—Anxiety—Temozolomide—brain cancer	0.000306	0.00241	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—PPP1R12A—brain cancer	0.000306	0.00483	CbGpPWpGaD
Trimethoprim—Headache—Procarbazine—brain cancer	0.000305	0.0024	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000305	0.0024	CcSEcCtD
Trimethoprim—DHFR—spinal cord—brain cancer	0.000304	0.0411	CbGeAlD
Trimethoprim—Immune system disorder—Etoposide—brain cancer	0.000299	0.00236	CcSEcCtD
Trimethoprim—Mediastinal disorder—Etoposide—brain cancer	0.000299	0.00235	CcSEcCtD
Trimethoprim—DHFR—G1/S Transition—PCNA—brain cancer	0.000299	0.00472	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000298	0.00471	CbGpPWpGaD
Trimethoprim—Thrombocytopenia—Carmustine—brain cancer	0.000298	0.00235	CcSEcCtD
Trimethoprim—Body temperature increased—Hydroxyurea—brain cancer	0.000298	0.00235	CcSEcCtD
Trimethoprim—Confusional state—Temozolomide—brain cancer	0.000297	0.00234	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000295	0.00466	CbGpPWpGaD
Trimethoprim—Anaphylactic shock—Temozolomide—brain cancer	0.000294	0.00232	CcSEcCtD
Trimethoprim—TYMS—G1/S Transition—CCNE1—brain cancer	0.000294	0.00465	CbGpPWpGaD
Trimethoprim—Anorexia—Carmustine—brain cancer	0.00029	0.00229	CcSEcCtD
Trimethoprim—Nausea—Procarbazine—brain cancer	0.000289	0.00228	CcSEcCtD
Trimethoprim—Nervous system disorder—Temozolomide—brain cancer	0.000288	0.00227	CcSEcCtD
Trimethoprim—Thrombocytopenia—Temozolomide—brain cancer	0.000288	0.00227	CcSEcCtD
Trimethoprim—Skin disorder—Temozolomide—brain cancer	0.000286	0.00225	CcSEcCtD
Trimethoprim—DHFR—Fluoropyrimidine Activity—TP53—brain cancer	0.000285	0.00451	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000284	0.00449	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—RELA—brain cancer	0.000284	0.00448	CbGpPWpGaD
Trimethoprim—Anorexia—Temozolomide—brain cancer	0.00028	0.00221	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00028	0.00442	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Hydroxyurea—brain cancer	0.000277	0.00219	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Carmustine—brain cancer	0.000277	0.00219	CcSEcCtD
Trimethoprim—TYMS—endocrine gland—brain cancer	0.000276	0.0373	CbGeAlD
Trimethoprim—Insomnia—Carmustine—brain cancer	0.000275	0.00217	CcSEcCtD
Trimethoprim—DHFR—endocrine gland—brain cancer	0.000274	0.037	CbGeAlD
Trimethoprim—TYMS—head—brain cancer	0.000273	0.0369	CbGeAlD
Trimethoprim—DHFR—E2F transcription factor network—CDKN2A—brain cancer	0.000272	0.0043	CbGpPWpGaD
Trimethoprim—Dyspnoea—Carmustine—brain cancer	0.000271	0.00214	CcSEcCtD
Trimethoprim—DHFR—head—brain cancer	0.00027	0.0365	CbGeAlD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.00027	0.00426	CbGpPWpGaD
Trimethoprim—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000268	0.00211	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—PPP1R12A—brain cancer	0.000267	0.00421	CbGpPWpGaD
Trimethoprim—Insomnia—Temozolomide—brain cancer	0.000266	0.0021	CcSEcCtD
Trimethoprim—Decreased appetite—Carmustine—brain cancer	0.000265	0.00209	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Carmustine—brain cancer	0.000263	0.00207	CcSEcCtD
Trimethoprim—Dyspnoea—Temozolomide—brain cancer	0.000262	0.00207	CcSEcCtD
Trimethoprim—TYMS—G1/S Transition—PCNA—brain cancer	0.00026	0.00412	CbGpPWpGaD
Trimethoprim—Constipation—Carmustine—brain cancer	0.00026	0.00205	CcSEcCtD
Trimethoprim—Vertigo—Etoposide—brain cancer	0.000259	0.00204	CcSEcCtD
Trimethoprim—Dyspepsia—Temozolomide—brain cancer	0.000259	0.00204	CcSEcCtD
Trimethoprim—Leukopenia—Etoposide—brain cancer	0.000258	0.00203	CcSEcCtD
Trimethoprim—Diarrhoea—Hydroxyurea—brain cancer	0.000258	0.00203	CcSEcCtD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000256	0.00405	CbGpPWpGaD
Trimethoprim—Decreased appetite—Temozolomide—brain cancer	0.000256	0.00202	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—IL2—brain cancer	0.000255	0.00404	CbGpPWpGaD
Trimethoprim—Gastrointestinal disorder—Temozolomide—brain cancer	0.000254	0.002	CcSEcCtD
Trimethoprim—Loss of consciousness—Etoposide—brain cancer	0.000253	0.002	CcSEcCtD
Trimethoprim—Cough—Etoposide—brain cancer	0.000252	0.00198	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000252	0.00398	CbGpPWpGaD
Trimethoprim—Constipation—Temozolomide—brain cancer	0.000252	0.00198	CcSEcCtD
Trimethoprim—Feeling abnormal—Carmustine—brain cancer	0.000251	0.00198	CcSEcCtD
Trimethoprim—Convulsion—Etoposide—brain cancer	0.00025	0.00197	CcSEcCtD
Trimethoprim—TYMS—central nervous system—brain cancer	0.000249	0.0336	CbGeAlD
Trimethoprim—TYMS—Fluoropyrimidine Activity—TP53—brain cancer	0.000249	0.00394	CbGpPWpGaD
Trimethoprim—Dizziness—Hydroxyurea—brain cancer	0.000249	0.00196	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Carmustine—brain cancer	0.000249	0.00196	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000248	0.00392	CbGpPWpGaD
Trimethoprim—DHFR—central nervous system—brain cancer	0.000247	0.0333	CbGeAlD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000245	0.00387	CbGpPWpGaD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000244	0.00192	CcSEcCtD
Trimethoprim—TYMS—cerebellum—brain cancer	0.000244	0.0329	CbGeAlD
Trimethoprim—Feeling abnormal—Temozolomide—brain cancer	0.000242	0.00191	CcSEcCtD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000242	0.00382	CbGpPWpGaD
Trimethoprim—DHFR—cerebellum—brain cancer	0.000241	0.0326	CbGeAlD
Trimethoprim—Body temperature increased—Carmustine—brain cancer	0.000241	0.0019	CcSEcCtD
Trimethoprim—Abdominal pain—Carmustine—brain cancer	0.000241	0.0019	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Temozolomide—brain cancer	0.000241	0.0019	CcSEcCtD
Trimethoprim—Vomiting—Hydroxyurea—brain cancer	0.000239	0.00189	CcSEcCtD
Trimethoprim—Rash—Hydroxyurea—brain cancer	0.000237	0.00187	CcSEcCtD
Trimethoprim—Confusional state—Etoposide—brain cancer	0.000237	0.00187	CcSEcCtD
Trimethoprim—Dermatitis—Hydroxyurea—brain cancer	0.000237	0.00187	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—CDKN2A—brain cancer	0.000237	0.00375	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000236	0.00373	CbGpPWpGaD
Trimethoprim—Headache—Hydroxyurea—brain cancer	0.000236	0.00186	CcSEcCtD
Trimethoprim—Anaphylactic shock—Etoposide—brain cancer	0.000235	0.00186	CcSEcCtD
Trimethoprim—Urticaria—Temozolomide—brain cancer	0.000234	0.00184	CcSEcCtD
Trimethoprim—Body temperature increased—Temozolomide—brain cancer	0.000233	0.00183	CcSEcCtD
Trimethoprim—Abdominal pain—Temozolomide—brain cancer	0.000233	0.00183	CcSEcCtD
Trimethoprim—Thrombocytopenia—Etoposide—brain cancer	0.00023	0.00182	CcSEcCtD
Trimethoprim—Skin disorder—Etoposide—brain cancer	0.000229	0.0018	CcSEcCtD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000228	0.00361	CbGpPWpGaD
Trimethoprim—Anorexia—Etoposide—brain cancer	0.000224	0.00177	CcSEcCtD
Trimethoprim—Hypersensitivity—Carmustine—brain cancer	0.000224	0.00177	CcSEcCtD
Trimethoprim—Nausea—Hydroxyurea—brain cancer	0.000224	0.00176	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000219	0.00347	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000217	0.00344	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Temozolomide—brain cancer	0.000217	0.00171	CcSEcCtD
Trimethoprim—ABCB1—blood vessel—brain cancer	0.000213	0.0288	CbGeAlD
Trimethoprim—Dyspnoea—Etoposide—brain cancer	0.00021	0.00165	CcSEcCtD
Trimethoprim—Diarrhoea—Carmustine—brain cancer	0.000208	0.00164	CcSEcCtD
Trimethoprim—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000208	0.00329	CbGpPWpGaD
Trimethoprim—Pruritus—Temozolomide—brain cancer	0.000208	0.00164	CcSEcCtD
Trimethoprim—Decreased appetite—Etoposide—brain cancer	0.000205	0.00161	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Etoposide—brain cancer	0.000203	0.0016	CcSEcCtD
Trimethoprim—Dizziness—Carmustine—brain cancer	0.000201	0.00159	CcSEcCtD
Trimethoprim—Constipation—Etoposide—brain cancer	0.000201	0.00159	CcSEcCtD
Trimethoprim—Diarrhoea—Temozolomide—brain cancer	0.000201	0.00159	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.0002	0.00315	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000199	0.00314	CbGpPWpGaD
Trimethoprim—TYMS—brain—brain cancer	0.000198	0.0267	CbGeAlD
Trimethoprim—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000197	0.00311	CbGpPWpGaD
Trimethoprim—DHFR—brain—brain cancer	0.000196	0.0264	CbGeAlD
Trimethoprim—Dizziness—Temozolomide—brain cancer	0.000194	0.00153	CcSEcCtD
Trimethoprim—Feeling abnormal—Etoposide—brain cancer	0.000194	0.00153	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000194	0.00306	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000194	0.00306	CbGpPWpGaD
Trimethoprim—Vomiting—Carmustine—brain cancer	0.000194	0.00153	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Etoposide—brain cancer	0.000192	0.00152	CcSEcCtD
Trimethoprim—DHFR—Disease—DTX2—brain cancer	0.000192	0.00304	CbGpPWpGaD
Trimethoprim—Rash—Carmustine—brain cancer	0.000192	0.00151	CcSEcCtD
Trimethoprim—Dermatitis—Carmustine—brain cancer	0.000192	0.00151	CcSEcCtD
Trimethoprim—Headache—Carmustine—brain cancer	0.000191	0.0015	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00019	0.003	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDK4—brain cancer	0.00019	0.003	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000188	0.00297	CbGpPWpGaD
Trimethoprim—Vomiting—Temozolomide—brain cancer	0.000187	0.00147	CcSEcCtD
Trimethoprim—Urticaria—Etoposide—brain cancer	0.000187	0.00147	CcSEcCtD
Trimethoprim—Abdominal pain—Etoposide—brain cancer	0.000186	0.00147	CcSEcCtD
Trimethoprim—Body temperature increased—Etoposide—brain cancer	0.000186	0.00147	CcSEcCtD
Trimethoprim—Rash—Temozolomide—brain cancer	0.000185	0.00146	CcSEcCtD
Trimethoprim—Dermatitis—Temozolomide—brain cancer	0.000185	0.00146	CcSEcCtD
Trimethoprim—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000185	0.00292	CbGpPWpGaD
Trimethoprim—Headache—Temozolomide—brain cancer	0.000184	0.00145	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—MYC—brain cancer	0.000184	0.00291	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—SIRT1—brain cancer	0.000182	0.00288	CbGpPWpGaD
Trimethoprim—Nausea—Carmustine—brain cancer	0.000181	0.00142	CcSEcCtD
Trimethoprim—CYP2C8—pituitary gland—brain cancer	0.000175	0.0237	CbGeAlD
Trimethoprim—Nausea—Temozolomide—brain cancer	0.000175	0.00138	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000175	0.00276	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000174	0.00275	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Etoposide—brain cancer	0.000173	0.00137	CcSEcCtD
Trimethoprim—Pruritus—Etoposide—brain cancer	0.000167	0.00131	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000166	0.00263	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000166	0.00263	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—TP53—brain cancer	0.000164	0.00259	CbGpPWpGaD
Trimethoprim—Diarrhoea—Etoposide—brain cancer	0.000161	0.00127	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—MYC—brain cancer	0.000161	0.00254	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.00016	0.00253	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00016	0.00253	CbGpPWpGaD
Trimethoprim—Dizziness—Etoposide—brain cancer	0.000156	0.00123	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—SKP2—brain cancer	0.000155	0.00245	CbGpPWpGaD
Trimethoprim—Vomiting—Etoposide—brain cancer	0.00015	0.00118	CcSEcCtD
Trimethoprim—Rash—Etoposide—brain cancer	0.000148	0.00117	CcSEcCtD
Trimethoprim—Dermatitis—Etoposide—brain cancer	0.000148	0.00117	CcSEcCtD
Trimethoprim—Headache—Etoposide—brain cancer	0.000147	0.00116	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000145	0.00229	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000144	0.00227	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HES5—brain cancer	0.000141	0.00223	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CCND1—brain cancer	0.00014	0.00222	CbGpPWpGaD
Trimethoprim—Nausea—Etoposide—brain cancer	0.00014	0.0011	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.00014	0.00221	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—SKP2—brain cancer	0.000139	0.00219	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDK6—brain cancer	0.000138	0.00219	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—CDK4—brain cancer	0.000138	0.00218	CbGpPWpGaD
Trimethoprim—CYP2C8—endocrine gland—brain cancer	0.000136	0.0184	CbGeAlD
Trimethoprim—TYMS—Cell Cycle, Mitotic—SKP2—brain cancer	0.000135	0.00214	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000135	0.00214	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—MYC—brain cancer	0.000134	0.00211	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000131	0.00208	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDK6—brain cancer	0.000124	0.00195	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000123	0.00194	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—SKP2—brain cancer	0.000121	0.00191	CbGpPWpGaD
Trimethoprim—CYP2C9—endocrine gland—brain cancer	0.000121	0.0163	CbGeAlD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDK6—brain cancer	0.000121	0.00191	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—MYC—brain cancer	0.000117	0.00184	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000115	0.00181	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—MYC—brain cancer	0.000113	0.00178	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000109	0.00172	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP2C9—brain cancer	0.000109	0.00172	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDK6—brain cancer	0.000108	0.0017	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000106	0.00167	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000105	0.00166	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000104	0.00165	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000104	0.00164	CbGpPWpGaD
Trimethoprim—ABCB1—telencephalon—brain cancer	0.000103	0.014	CbGeAlD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—MYC—brain cancer	9.83e-05	0.00155	CbGpPWpGaD
Trimethoprim—CYP2C8—brain—brain cancer	9.72e-05	0.0131	CbGeAlD
Trimethoprim—DHFR—Cell Cycle—BRCA2—brain cancer	9.61e-05	0.00152	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IDH1—brain cancer	9.5e-05	0.0015	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP2C9—brain cancer	9.49e-05	0.0015	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCNE1—brain cancer	9.31e-05	0.00147	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.28e-05	0.00147	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—BSG—brain cancer	9.25e-05	0.00146	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—PCNA—brain cancer	9.23e-05	0.00146	CbGpPWpGaD
Trimethoprim—CYP3A4—endocrine gland—brain cancer	9.2e-05	0.0124	CbGeAlD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.19e-05	0.00145	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	9.1e-05	0.00144	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCNE1—brain cancer	9.09e-05	0.00144	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HEY1—brain cancer	9e-05	0.00142	CbGpPWpGaD
Trimethoprim—DHFR—Disease—DLL1—brain cancer	8.83e-05	0.0014	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	8.63e-05	0.00136	CbGpPWpGaD
Trimethoprim—ABCB1—gonad—brain cancer	8.62e-05	0.0116	CbGeAlD
Trimethoprim—ABCB1—pituitary gland—brain cancer	8.41e-05	0.0114	CbGeAlD
Trimethoprim—TYMS—Cell Cycle—BRCA2—brain cancer	8.39e-05	0.00133	CbGpPWpGaD
Trimethoprim—CYP3A4—central nervous system—brain cancer	8.29e-05	0.0112	CbGeAlD
Trimethoprim—DHFR—Cell Cycle—PCNA—brain cancer	8.25e-05	0.0013	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCNE1—brain cancer	8.13e-05	0.00128	CbGpPWpGaD
Trimethoprim—ABCB1—medulla oblongata—brain cancer	8.12e-05	0.011	CbGeAlD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.09e-05	0.00128	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—BSG—brain cancer	8.07e-05	0.00128	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—PCNA—brain cancer	8.05e-05	0.00127	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDK4—brain cancer	7.98e-05	0.00126	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—IDH1—brain cancer	7.95e-05	0.00126	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.55e-05	0.00119	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	7.55e-05	0.00119	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SHH—brain cancer	7.51e-05	0.00119	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ENO2—brain cancer	7.51e-05	0.00119	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.45e-05	0.00118	CbGpPWpGaD
Trimethoprim—ABCB1—midbrain—brain cancer	7.42e-05	0.01	CbGeAlD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.28e-05	0.00115	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	7.28e-05	0.00115	CbGpPWpGaD
Trimethoprim—ABCB1—spinal cord—brain cancer	7.24e-05	0.00978	CbGeAlD
Trimethoprim—TYMS—Cell Cycle—PCNA—brain cancer	7.2e-05	0.00114	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDK4—brain cancer	7.13e-05	0.00113	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDK4—brain cancer	6.96e-05	0.0011	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—IDH1—brain cancer	6.94e-05	0.0011	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	6.82e-05	0.00108	CbGpPWpGaD
Trimethoprim—ABCB1—endocrine gland—brain cancer	6.52e-05	0.0088	CbGeAlD
Trimethoprim—ABCB1—head—brain cancer	6.43e-05	0.00869	CbGeAlD
Trimethoprim—DHFR—Metabolism—ENO2—brain cancer	6.29e-05	0.000993	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDK4—brain cancer	6.22e-05	0.000983	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.11e-05	0.000966	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2A—brain cancer	6.1e-05	0.000963	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.98e-05	0.000945	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL2—brain cancer	5.95e-05	0.000941	CbGpPWpGaD
Trimethoprim—ABCB1—central nervous system—brain cancer	5.87e-05	0.00793	CbGeAlD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—brain cancer	5.87e-05	0.000928	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.86e-05	0.000927	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.84e-05	0.000923	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.79e-05	0.000915	CbGpPWpGaD
Trimethoprim—ABCB1—cerebellum—brain cancer	5.74e-05	0.00775	CbGeAlD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.52e-05	0.000872	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ENO2—brain cancer	5.49e-05	0.000867	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2A—brain cancer	5.45e-05	0.000861	CbGpPWpGaD
Trimethoprim—DHFR—Disease—VAV1—brain cancer	5.42e-05	0.000857	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.38e-05	0.000851	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2A—brain cancer	5.32e-05	0.000841	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND1—brain cancer	5.15e-05	0.000814	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.13e-05	0.000811	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—brain cancer	5.06e-05	0.0008	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2A—brain cancer	4.76e-05	0.000752	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HES1—brain cancer	4.66e-05	0.000737	CbGpPWpGaD
Trimethoprim—ABCB1—brain—brain cancer	4.66e-05	0.0063	CbGeAlD
Trimethoprim—DHFR—Cell Cycle—CCND1—brain cancer	4.6e-05	0.000728	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND1—brain cancer	4.49e-05	0.00071	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.49e-05	0.00071	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PDGFRA—brain cancer	4.44e-05	0.000702	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.44e-05	0.000701	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.18e-05	0.00066	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—brain cancer	4.13e-05	0.000653	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND1—brain cancer	4.02e-05	0.000635	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IRS2—brain cancer	3.9e-05	0.000616	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—brain cancer	3.69e-05	0.000584	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—brain cancer	3.6e-05	0.00057	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.48e-05	0.000551	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APC—brain cancer	3.44e-05	0.000544	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2C9—brain cancer	3.36e-05	0.000531	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.24e-05	0.000512	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—brain cancer	3.22e-05	0.000509	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—brain cancer	3.03e-05	0.000479	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2C9—brain cancer	2.93e-05	0.000463	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CG—brain cancer	2.88e-05	0.000456	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.86e-05	0.000453	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BSG—brain cancer	2.86e-05	0.000452	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.84e-05	0.000448	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB2—brain cancer	2.67e-05	0.000423	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—brain cancer	2.65e-05	0.000418	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CG—brain cancer	2.52e-05	0.000398	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.5e-05	0.000395	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BSG—brain cancer	2.49e-05	0.000393	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—IDH1—brain cancer	2.46e-05	0.000388	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CTNNB1—brain cancer	2.34e-05	0.00037	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BSG—brain cancer	2.33e-05	0.000368	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.3e-05	0.000363	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.25e-05	0.000355	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—IDH1—brain cancer	2.14e-05	0.000338	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—brain cancer	2.04e-05	0.000322	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2e-05	0.000316	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—IDH1—brain cancer	2e-05	0.000316	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ENO2—brain cancer	1.94e-05	0.000307	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—brain cancer	1.89e-05	0.000299	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.89e-05	0.000298	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—brain cancer	1.85e-05	0.000293	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2C9—brain cancer	1.8e-05	0.000285	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ENO2—brain cancer	1.69e-05	0.000267	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.63e-05	0.000257	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ENO2—brain cancer	1.58e-05	0.00025	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BSG—brain cancer	1.53e-05	0.000242	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—IDH1—brain cancer	1.32e-05	0.000208	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ENO2—brain cancer	1.04e-05	0.000165	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—brain cancer	8.91e-06	0.000141	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—brain cancer	7.76e-06	0.000123	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—brain cancer	7.25e-06	0.000115	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—brain cancer	4.78e-06	7.56e-05	CbGpPWpGaD
